Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
13 mai 2024 16h03 HE
|
Augmedix Inc
SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended...
Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care
09 mai 2024 08h30 HE
|
Holdco Nuvo Group D.G Ltd.
TEL AVIV, Israel, May 09, 2024 (GLOBE NEWSWIRE) -- Holdco Nuvo Group D.G Ltd (NASDAQ: NUVO) (“Nuvo”), a pioneer in remote pregnancy monitoring, today announced the expansion of its board of...
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
03 mai 2024 07h00 HE
|
Augmedix Inc
SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will...
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024
30 avr. 2024 07h00 HE
|
Augmedix Inc
SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results...
Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List
25 avr. 2024 16h05 HE
|
Augmedix Inc
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek’s list of The World’s Best...
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
24 avr. 2024 07h00 HE
|
Augmedix Inc
SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go...
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
10 avr. 2024 12h04 HE
|
Raydiant Oximetry
The FDA has approved the Investigational Device Exemption (IDE) of Lumerah for an Early Feasibility Study (EFS) of pregnant women during labor and delivery
Impact of AI, Advancements in Healthcare Taking Center Stage at AAPA 2024
10 avr. 2024 09h18 HE
|
American Academy of PAs
ALEXANDRIA, Va., April 10, 2024 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) will explore cutting-edge advancements reshaping the foundations of healthcare during AAPA...
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
09 avr. 2024 07h00 HE
|
Augmedix Inc
SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (Nasdaq: AUGX), a...
Premier Health Announces the Appointment of Bruno Morel as its New CTO
08 avr. 2024 17h30 HE
|
Premier Health of America Inc.
Premier Health hires new Chief Technology Officer to lead health care platform AI efforts.